US Bancorp’s Viridian Therapeutics VRDN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $27.9K | Buy |
1,994
+504
| +34% | +$7.05K | ﹤0.01% | 3042 |
|
|
2025
Q1 | $20.1K | Buy |
1,490
+592
| +66% | +$7.98K | ﹤0.01% | 3157 |
|
|
2024
Q4 | $17.2K | Buy |
+898
| New | +$17.2K | ﹤0.01% | 3217 |
|
|
2023
Q4 | – | Sell |
-37
| Closed | -$568 | – | 4125 |
|
|
2023
Q3 | $568 | Sell |
37
-19,068
| -100% | -$293K | ﹤0.01% | 3804 |
|
|
2023
Q2 | $455K | Sell |
19,105
-1,390
| -7% | -$33.1K | ﹤0.01% | 1437 |
|
|
2023
Q1 | $521K | Buy |
20,495
+9,273
| +83% | +$236K | ﹤0.01% | 1382 |
|
|
2022
Q4 | $328K | Buy |
+11,222
| New | +$328K | ﹤0.01% | 1604 |
|
|
2019
Q1 | – | Sell |
-1,000
| Closed | -$3K | – | 3658 |
|
|
2018
Q4 | $3K | Hold |
1,000
| – | – | ﹤0.01% | 3348 |
|
|
2018
Q3 | $6K | Hold |
1,000
| – | – | ﹤0.01% | 3282 |
|
|
2018
Q2 | $6K | Hold |
1,000
| – | – | ﹤0.01% | 3292 |
|
|
2018
Q1 | $7K | Hold |
1,000
| – | – | ﹤0.01% | 3258 |
|
|
2017
Q4 | $10K | Buy |
+1,000
| New | +$10K | ﹤0.01% | 3147 |
|